CINTERION, Healthimo and Philips Respironics Selected as Mobile Health Expo 2010 Award Winners

Nov. 18, 2010 - PRLog -- CINTERION, the leading global manufacturer of cellular machine-to-machine (M2M) modules, today announced it was selected, jointly with healthimo and Philips Respironics, for two Mobile Health Expo 2010 Awards in the Best Mobile Healthcare Device category. Healthimo was recognized for its groundbreaking diabetes education program and Philips Respironics for its innovative System One sleep therapy solution. CINTERION was honored with two awards for powering reliable, always-on M2M wireless communications for both mobile health (mHealth) solutions.  

“The Mobile Health Expo 2010 Award winners represent companies and individuals who have had a profound impact on advancing the convergence of mobile technology and healthcare,” said Wendy Thomas, founder and CEO of Mobile Health Expo. “CINTERION, healthimo, Philips Respironics and the other award winners have set a high standard for creating and delivering mobile healthcare solutions now and in the future.”

“CINTERION and early implementers such as healthimo and Philips Respironics are driving the trend toward mobile healthcare by improving patient outcomes and streamlining administration while reducing the cost of treatment,” said Norbert Muhrer, CEO, CINTERION. “CINTERION’s established, proven expertise in mHealth and relevant industries with similar security requirements makes us the ideal communications technology to continue pushing this industry forward.”

The healthimo diabetes education program was designed to help the estimated 220 million people worldwide struggling to manage the global diabetes and pre-diabetes pandemic. Adopted by major US & UK health plans and currently used by more than 20,000 patients, healthimo’s clinically proven, outcome-driven diabetes education program combines the world's most accurate and reliable diabetes data with the ease and convenience of wireless communications. The program relies on the CINTERION-powered GlucoMON mHealth device to wirelessly send blood glucose data and relevant education between healthimo's clinical operations center and the patient. Ease of use and timely feedback helps patients better understand ways to control blood sugar levels and thereby avoid costly and debilitating complications.  

Philips Respironics System One provides treatment for sleep apnea by delivering a specific flow of pressurized air through a mask to keep the airway open. For the first time in sleep apnea treatment, System One combines mobility with secure, two-way wireless communications allowing patients to receive treatment and prescription air pressure updates at home or anywhere they travel while helping healthcare providers meet rigorous new reporting standards. System One uses CINTERION’s M2M communications technology to securely send sophisticated patient breathing data from the device to the EncoreAnywhere™ Web-based data management platform. Physicians log on to EncoreAnywhere to obtain timely, detailed, breathing reports and respond with prescription air pressure changes sent over-the-air to the device providing appropriate treatment intervention and improved disease management.

For more information about CINTERION, visit us at MEDICA 2010 Düsseldorf, Hall 15 Booth #D04 or online at www.cinterion.com.

# # #

About CINTERION
CINTERION is the worldwide leading supplier of cellular machine-to-machine (M2M) communication modules and combines unparalleled M2M engineering expertise and localized worldwide customer support with a strong portfolio of high-quality GSM, GPRS, EDGE, UMTS and HSPA products. CINTERION is a reliable partner and valued by many vertical market customers for its award-winning modules which enable machines, equipment and vehicles to communicate over wireless networks helping enterprises dramatically cut costs and increase productivity and efficiency. CINTERION is part of the Gemalto group (Euronext NL 0000400653 GTO), the world leader in digital security with 2009 annual revenues of €1.65 billion, and over 10,000 employees operating out of 75 offices, with research and service centers in 41 countries. For more information, please visit: www.cinterion.com.